NCT03925870 KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03922230 Exploration and Verification of DNA Methylolation in Early Screening of Esophageal Cancer Status UNKNOWN Phase N/A
NCT03913182 Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT03888092 Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification Status COMPLETED Phase PHASE1/PHASE2
NCT03857763 A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03833466 Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo) Status UNKNOWN Phase PHASE2
NCT03817658 A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC Status UNKNOWN Phase PHASE2
NCT03817567 Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE1/PHASE2
NCT03797625 Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas Status COMPLETED Phase PHASE2
NCT03792347 Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus Status COMPLETED Phase PHASE1
NCT03790553 Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma Status UNKNOWN Phase PHASE3
NCT03766178 Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03748134 Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 ) Status COMPLETED Phase PHASE3
NCT03713749 Robotic-assisted Esophagectomy vs. Video-Assisted Thoracoscopic Esophagectomy(REVATE) Trial Status UNKNOWN Phase NA
NCT03660449 Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03623737 Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC Status UNKNOWN Phase PHASE2/PHASE3
NCT03603756 SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer Status UNKNOWN Phase PHASE2
NCT03600831 Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT03592407 Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer Status WITHDRAWN Phase PHASE2
NCT03474341 Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Status UNKNOWN Phase N/A